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ABSTRACT 
Mapping of protein-protein interactions (PPIs) is critical for understanding protein 
function and complex biological processes. Here, we present DULIP, a dual 
luminescence-based co-immunoprecipitation assay, for systematic PPI mapping in 
mammalian cells. DULIP is a second-generation luminescence-based PPI screening 
method for the systematic and quantitative analysis of co-immunoprecipitations using 
two different luciferase tags. Benchmarking studies with positive and negative PPI 
reference sets revealed that DULIP allows the detection of interactions with high 
sensitivity and specificity. Furthermore, the analysis of a PPI reference set with 
known binding affinities demonstrated that both low- and high-affinity interactions can 
be detected with DULIP assays. Finally, using the well-characterized interaction 
between Syntaxin-1 and Munc18, we found that DULIP is capable of detecting the 
effects of point mutations on interaction strength. Taken together, our studies 
demonstrate that DULIP is a sensitive and reliable method of great utility for 
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systematic interactome research. It can be applied for interaction screening as well 
as for the validation of PPIs in mammalian cells. Moreover, DULIP permits the 
specific analysis of mutation-dependent binding patterns. 
 
HIGHLIGHTS 
• DULIP is a dual luminescence-based co-immunoprecipitation assay suitable 
for systematic analysis of PPIs  
• DULIP generates quantitative interaction scores 
• DULIP reliably detects PPIs with high sensitivity and specificity 
• DULIP measures the effects of point mutations on interaction strength  
 
KEYWORDS 
Systematic protein-protein interaction screening; luminescence normalization; 
quantitative interaction score; detection of low- and high-affinity interactions; disease-
mutation detection; quantification of interaction strength; DULIP.  
 
ABREVIATIONS 
Protein-protein interaction (PPI); dual luminescence-based co-immunoprecipitation 
(DULIP); yeast two-hybrid (Y2H); kinase substrate sensor (KISS); single-molecule 
pull-down (SiMPull); mammalian-membrane two-hybrid assay (MaMTH); 
luminescence-based mammalian interactome mapping (LUMIER); Renilla luciferase 
(RL); firefly luciferase (FL); Protein A (PA); Gateway cassette (GW); normalized 
luminescence-based interaction ratio (NIR); background corrected NIR (cNIR); 
positive reference set (PRS); negative reference set (NRS); affinity-based interaction 
reference set (AIRS); Homo sapiens positive reference set (hsPRS-v1); Homo 
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sapiens random reference set (hsRRS-v1); human integrated protein-protein 
interaction reference (HIPPIE). 
 
INTRODUCTION 
Protein-protein interactions (PPIs) play a crucial role in many biological 
processes, including cell signaling, gene expression regulation and the trafficking of 
membrane vesicles 1; 2. Therefore, the identification and characterization of PPIs is 
considered an important step towards elucidating the function of complex biological 
systems as well as the pathobiological mechanisms in diseases 3; 4; 5; 6. Various yeast 
two-hybrid and affinity purification-based methods have proven to be successful for 
the identification and validation of PPIs5; 7; 8. Both types of methods yield reliable, 
largely complementary PPI data sets, which allow the creation of interactome 
networks involving whole proteomes or particular cellular pathways and disease 
processes of interest9; 10; 11; 12; 13; 14; 15. 
To this day, systematic mapping of binary interactions between human 
proteins has been predominantly performed in yeast cells3; 16; 17; 18. Despite being 
highly efficient and previously successful, this approach has the disadvantage of 
placing human proteins in an artificial environment, which may lead to abnormal 
protein modifications and increased detection of false positive PPIs19. Thus, the 
development and validation of reliable assays for the identification and systematic 
screening of human PPIs in mammalian cells are of high importance for advanced 
interactome research1; 19.  
Several assays for the detection of binary human PPIs based on mammalian 
cells have been developed in recent years. This includes methods such as KISS 20, 
SiMPull21; 22, MaMTH23 and different variants of the LUMIER assay24; 25; 26; 27; 28; 29. All 
these methods use different molecular principles and readouts for PPI detection. 
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Among the currently available methods only the LUMIER method (for luminescence-
based mammalian interactome mapping) has been applied in systematic, large-scale 
PPI screening efforts28; 30; 31. LUMIER is a luminescence-based co-
immunprecipitation assay, in which the Renilla luciferase (RL) enzyme is fused to 
proteins of interest. These RL-tagged fusion proteins are co-expressed with FLAG-
tagged fusion proteins in HEK293 cells and interactions are detected by RL 
enzymatic assays on immunoprecipitates24. Although this method is, in principle, 
suitable for high-throughput PPI mapping in mammalian cells 24, bait protein 
immunoprecipitation cannot easily be quantified. To overcome this problem, Taipale 
et al. (2012) have established an antibody-based method to systematically measure 
the abundance of precipitated FLAG-tagged proteins in LUMIER assays28.  
Here, we present a second generation LUMIER PPI screening assay, which 
allows quantification of both bait and prey hybrid proteins using two different 
luciferase tags. DULIP (for dual luminescence-based co-immunoprecipitation assay) 
detects PPIs between protein A-(PA)-RL-tagged bait and firefly luciferase (FL)-
tagged prey proteins in mammalian cells. Benchmarking studies with positive and 
negative reference sets revealed that DULIP is a powerful interaction screening 
method, which enables the detection of human PPIs with high sensitivity and 
specificity. Furthermore, DULIP can detect both low- and high-affinity interactions as 
well as the effects of point mutations on interaction strength. We suggest that DULIP 
is suitable for both systematic screening and validation of PPIs in mammalian cells. 
Potential applications of the method are discussed.  
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RESULTS 
To establish a dual luminescence-based co-immunoprecipitation (DULIP) 
interaction detection assay, we first constructed the Gateway-compatible plasmids 
pPA-RL-GW and pGW-RL-PA, from which bait proteins with N- or C-terminal protein-
A-Renilla luciferase (PA-RL) tags are expressed (Fig. 1a). Similarly, we constructed 
pFL-V5-GW and pGW-FL-V5 plasmids for the expression of prey proteins harboring 
N- or C-terminal firefly luciferase (FL) tags.  
Next, cDNA fragments encoding bait or prey fusion proteins were inserted in 
the available plasmids for systematic interaction testing. For proof-of-principle 
experiments, we selected the proteins BAD and BCL2L1 because these proteins 
were previously shown to interact in various PPI detection assays32; 33. Using the 
Gateway cloning technology, we generated plasmids encoding the proteins PA-RL-
BAD (bait) and FL-BCL2L1 (prey) (Fig. 1b Table S1). Additionally, we constructed 
plasmids encoding the fusion proteins PA-RL-mCherry and FL-mCherry for control 
experiments. We hypothesized that an unrelated monomeric protein like mCherry 
should not specifically interact with BAD or BCL2L1 in co-immunoprecipitation 
experiments. Therefore, fusions with mCherry might be generally useful to assess 
non-specific interactions of tested bait and prey fusion proteins. To address the lack 
of data normalization in luminescence-based PPI assays34, which accounts for a high 
variability between experimental replicates, we additionally generated a tandem 
construct that encodes a PA-RL-FL hybrid protein (Fig. 1b). In this fusion protein FL 
is connected via a short peptide linker to the PA-RL fragment. The identities of the 
generated plasmids as well as their encoded hybrid proteins are summarized in 
Table S1. 
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DULIP assays facilitate the detection of the known interaction between BAD 
and BCL2L1 
To study the interaction, we performed four independent transfections of 
HEK293 cells in 96-well microtiter plates (Fig. 2a). This included the analysis of the 
protein pairs PA-RL-BAD/FL-BCL2L1, PA-RL-BAD/FL-mCherry (control 1) and PA-
RL-mCherry/FL-BCL2L1 (control 2) as well as the investigation of the hybrid protein 
PA-RL-FL (control 3). Transfected cells were lysed after 48 h and both RL and FL 
enzymatic activities (RLIN and FLIN) were quantified in crude protein extracts. We 
were able to measure RL and FL activities in all four cell lysates (Fig. 2b), suggesting 
that the expected recombinant hybrid proteins were indeed produced in the cells. 
Next, the PA-tagged bait proteins were immunoprecipitated from cell lysates using 
IgG-coated 384-well microtiter plates. After extensive washing the enzymatic 
activities of both RL and FL were quantified (RLOUT and FLOUT) in precipitated protein 
complexes. In this step, the measured RL activities indicate the successful 
immunoprecipitation (IP) of PA-tagged bait proteins, while the measured FL activities 
are indicative of the co-precipitated prey proteins (CoIP, Fig. 2a and 2c). In all four 
experiments, which were performed in parallel, the expected PA-tagged bait proteins 
were immunoprecipitated. However, high FLOUT activities were only measured for the 
tandem construct PA-RL-FL and the prey protein FL-BCL2L1 that was co-
precipitated with the bait protein PA-RL-BAD (Fig. 2c). For the interaction of interest 
PA-RL-BAD/FL-BCL2L1 in comparison to the control interactions PA-RL-BAD/FL-
mCherry and PA-RL-mCherry/FL-BCL2L1 a ~7- and a ~292-fold higher luciferase 
activity (FLOUT) was obtained, indicating that the method is suitable to distinguish 
between a proven PPI (BAD and BCL2L1) and negative control PPIs (e.g. PA-RL-
BAD/FL-Cherry). These results also confirm mCherry as a useful control protein that 
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can be applied more generally in DULIP assays to investigate non-specific 
background binding. 
As the co-immunoprecipitation efficiency of prey proteins depends on the 
immunoprecipitation efficiency of PA-tagged bait proteins, we calculated the 
luciferase activity ratios (FLOUT/RLOUT) for the interactions PA-RL-BAD/FL-BCL2L1, 
PA-RL-mCherry/FL-BCL2L1 and PA-RL-BAD/FL-mCherry. In addition, the 
FLOUT/RLOUT ratio was determined for the control protein PA-RL-FL. This ratio -
termed luciferase immunoprecipitation ratio (LIR) of control 3 - was subsequently 
utilized to normalize the luciferase activity ratios of the tested bait/prey combinations 
(interaction of interest and controls 1 and 2, see Fig. 2a). This revealed the 
normalized luminescence-based interaction ratios (NIRs, Fig. 2d) for the three tested 
interactions. NIRs indicate the success of prey protein co-immunoprecipitation in 
relation to the efficacy of bait protein immunoprecipitation. As shown in Fig. 2d, the 
calculated NIR for the interaction PA-RL-BAD/FL-BCL2L1 is 185- and 203-fold higher 
than the NIRs for the control interactions PA-RL-BAD/FL-mCherry and PA-RL-
mCherry/FL-BCL2L1, respectively. Thus, our normalization step significantly 
increases the specificity of PPI detection, allowing a clear distinction between 
positive and negative PPIs. 
Finally, we calculated a background corrected normalized luminescence-
based interaction ratio (cNIR, Fig. 2d) for PA-RL-BAD/FL-BCL2L1. We first 
compared the NIRs obtained for the control PPIs PA-RL-BAD/FL-mCherry and PA-
RL-mCherry/FL-BCL2L1 and identified the interaction with the higher value. Next, 
this value, here the NIR for the interaction PA-RL-BAD/FL-mCherry, was subtracted 
from the NIR of the interaction of interest, PA-RL-BAD/FL-BCL2L1. In the following 
systematic investigations of PPIs with DULIP assays cNIRs will be utilized as a 
quantitative measure in order to compare interaction data (see below). A detailed 
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step-by-step description of the calculations that lead to cNIRs can be found in the 
supplemental information (Fig. S1). 
 
Y2H and FRET assays confirm the interaction between BAD and BCL2L1  
First, we employed an established yeast two-hybrid (Y2H) interaction-mating 
assay3; 16 to examine the interaction between BAD and BCL2L1. We generated 
MATa yeast strains expressing the bait proteins LexA-BAD or LexA-mCherry and 
subsequently mated these strains on YPD plates with MATα strains expressing the 
prey proteins Gal4-BCL2L1 or Gal4-mCherry. Next, the generated diploid yeast 
strains were spotted onto selective plates; PPIs were identified through monitoring of 
yeast colony growth (Fig. S2a). For each tested interaction, 12 independent matings 
and three technical replicates were performed. We detected the interaction between 
LexA-BAD and Gal4-BCL2L1 in all mating experiments (100%, Fig. 3b), confirming 
the results of the DULIP assay (Fig. 2d). In strong contrast, the control PPIs LexA-
BAD/Gal4-mCherry and LexA-mCherry/Gal4-BCL2L1 were detected with significantly 
lower frequency (Fig. S2b), indicating that the Y2H method is capable of 
distinguishing between specific and non-specific PPIs.  
Finally, we also examined the interaction between BAD and BCL2L1 in 
mammalian cells using a sensitive FRET assay (Fig. S2c). In these experiments 
ECFP- and EYFP-tagged fusion proteins were co-produced in HEK293 cells and 
FRET efficiencies were determined using the sensitized emission method35; 36. For 
data comparison the hybrid fusion protein ECFP-EYFP was used as a positive 
control. It routinely showed FRET efficiencies of ~40% in various transfection 
experiments (Fig. S2c). In strong contrast, in cells co-producing the control proteins 
ECFP and EYFP only very low FRET values were obtained. However, we detected 
relatively high FRET efficiencies (~38%) in cells co-expressing the proteins ECFP-
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BAD/EYFP-BCL2L1 (Fig. S2c), confirming the results of Y2H and DULIP assays. As 
additional controls, we also examined the interactions ECFP-BAD/EYFP and 
ECFP/EYFP-BCL2L1, indicating that the fluorescent proteins EYFP and ECFP do not 
unspecifically interact with the tested proteins of interest.  
 
Assessment of assay quality 
To assess assay quality parameters such as sensitivity and specificity8; 20 
reference sets of positive and negative interacting pairs are required. To compile a 
positive reference set (PRS) of human PPIs we started with 181 interactions that 
possess a PPI confidence score of ≥0.99 in the HIPPIE database37. PPIs with such 
scores are considered as high confidence interactions, because they were previously 
shown to be detectable with multiple independent methods in various experiments37. 
From this PPI set, 25 protein pairs were randomly selected, of which 23 were finally 
examined in interaction tests (Fig. 3a and Table S2). To compile a negative reference 
set (NRS) we started with 114 PPIs from the Negatome database (v1.0). These 
interactions were not detectable with at least three independent methods in previous 
studies38, suggesting that they should also not be identified in DULIP assays. We 
randomly selected 30 protein pairs from this data set for systematic PPI analysis in 
mammalian cells (Fig. 3b, Table S3). 
Next, two expression plasmids were constructed for each selected protein, 
enabling its investigation either as a bait (PA-RL-tagged fusion) or as a prey (FL-
tagged fusion) in DULIP assays. Thus, all selected protein pairs were systematically 
analyzed as bait/prey (set a of reference PPIs) and prey/bait combinations (set b of 
reference PPIs) in mammalian cells (Tables S2 and S3). In total, 95 protein pairs 
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(PRS and NRS) were systematically tested in two independent experiments 
(experiment 1 and 2) in DULIP assays (Fig. S3a).  
As described above for the interaction between BAD and BCL2L1 (Fig. 2a-d), 
we performed four independent transfections in order to analyze a PPI of interest. In 
all these experiments, after cell lysis, both RL and FL activities were systematically 
quantified in protein extracts before and after co-immunoprecipitation of protein 
complexes. At this stage the obtained FLOUT values for all PPIs of interest, which 
indicate the efficiency of the co-immunoprecipitation, were divided by FLOUT values of 
control PPIs (controls 1 and 2, see Fig. 2a and Fig. S1) in order to obtain FLOUT-
based interaction control ratios (ICRs). Only PPIs with ICRs of ≥3 (see step 3 in Fig. 
S1) were considered for further analysis. This selection criterion was defined for 
systematic large-scale PPI detection studies to ensure that the FLOUT values for all 
tested PPIs of interest are significantly higher than the FLOUT values of the respective 
control PPIs (controls 1 and 2). Through this selection strategy 30 interactions in the 
NRS and 7 in the PRS were excluded from further analysis.  
As the production of prey proteins is critical for the success of co-
immunoprecipitation experiments, we next assessed the abundance of these proteins 
(FL fusions) in all prepared protein extracts. We used the frequency distribution and a 
fitted Gaussian function of all measured FLIN values to identify prey proteins that are 
not sufficiently produced in HEK293 cells (Fig. S3b). Prey proteins with FLIN values 
<µ-3σ were defined as not expressed and not considered for further data analysis. 
With this strategy, all of the interactions in the reference interaction sets (PRS and 
NRS) were considered for benchmarking studies (Fig. S3a).  
Next, we used a similar strategy to assess the immunoprecipitation of bait 
proteins (PA-tagged fusions) as a prerequisite for the successful co-
immunoprecipitation of prey proteins (Fig. S3c). Thus, PPIs with bait proteins that are 
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not sufficiently precipitated should not be considered for further data analysis. Using 
a fitted Gaussian function we defined 3 bait proteins with RLOUT values <µ-3σ (Fig. 
S3a). 5 PPIs harboring these bait proteins were excluded from further benchmarking 
studies. 
For the remaining 53 PPIs the corrected normalized luminescence-based 
interaction ratios (cNIRs), a quantitative measure of the potential interaction strength 
of proteins, were calculated (Fig. S4 a-d). We found that the cNIRs for the tested 
PPIs were highly reproducible in two independent DULIP experiments (r2 = ~0.98; 
Fig. 3c). Moreover, they covered a broad range of values, suggesting that the 
method detects PPIs with different binding affinities. We next used the ROC (receiver 
operating characteristic) analysis (Fig. 3d) to define the cutoff for the identification of 
“true” positive PPIs. Using a cNIR of 3 we observed a clear separation between 
known positive and potential false-positive PPIs. Thus, a cNIR cutoff of ≥ 3 was 
utilized to estimate the assay sensitivity. Under these conditions, 79.5% of the PPIs 
in the PRS were detected with the DULIP assay (Fig. 3e), while 3.3% of the PPIs in 
the NRS were identified. The results of the benchmarking studies are summarized in 
Fig. 3f and 3g.  
To more comprehensively evaluate the performance of DULIP, we next 
examined the assay’s detection rate of PPIs in the established reference sets 
hsPRS-v1 and hsRRS-v1, which were successfully applied previously to benchmark 
various PPI detection methods8; 20; 39. Like for the PPIs in the initially tested reference 
sets (Fig. 3a and b) all selected protein pairs were systematically analyzed as 
bait/prey and prey/bait combinations in mammalian cells (Fig. S5a and b). In these 
experiments, we detected PPIs in the positive reference set hsPRS-v1 and the 
random reference set hsRRS-v1 with a success rate of 35.4 and 3.7%, respectively 
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(Fig. 3e and Fig. S5 and S6), confirming that the established DULIP assay is a robust 
method, which allows the detection of PPIs with high sensitivity and specificity. 
 
DULIP allows the detection of both low- and high-affinity interactions 
To address the question whether DULIP can detect both low- and high-affinity 
PPIs, we additionally created an affinity-based interaction reference set (AIRS). It 
exclusively consists of interactions with known dissociation constants (Kds). To 
generate an AIRS, we selected PPIs from PDBind40 as well as from the PPI Affinity 
Database 2.041 and subsequently subcloned cDNAs encoding potential bait and prey 
fusion proteins into DULIP expression plasmids. In total, 57 affinity-based 
interactions were selected which were systematically tested as bait/prey and 
prey/bait combinations in DULIP assays (Fig. 4a). As shown in Fig. 4b, the selected 
interactions in AIRS indeed covered a broad spectrum of binding affinities, including 
both low- (59% of PPIs with a Kd <100 nM) and high-affinity (41% of PPIs with a Kd 
>100 nM) interactions. Using assay conditions identical to the ones applied for 
hsPRS-v1 and hsRRS-v1 (Fig. 3e), we detected interactions in AIRS with a success 
rate of 29.8% (17 of 57 tested PPIs). Strikingly, besides strong PPIs (Kd values in the 
nanomolar range), also relatively weak interactions (Kd values in the micromolar 
range) could be readily detected (Fig. 4c and d), supporting the hypothesis that both 
high- and low-affinity interactions can be identified with DULIP. However, our 
experiments clearly demonstrate that DULIP is more likely to detect higher affinity 
than lower affinity PPIs (Fig. 4c and d), substantiating previous observations that co-
immunoprecipiation-based PPI detection methods have a certain bias for stronger 
interactions42. 
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Next, we examined whether the published binding strengths (defined through 
Kd values) of PPIs in the AIRS correlate with calculated cNIR values obtained with 
DULIP assays (Tab. S5). As shown in Fig. 4e, we found a significant correlation 
between published Kd values and luminescence-based cNIRs, supporting the 
hypothesis that high cNIRs are an indication of strong interactions.  
 
Point mutations influence the detection of PPIs with DULIP assays  
Previous studies indicate that point mutations in proteins influence their 
binding affinities, which can be monitored with Y2H assays or other interaction 
detection methods18; 43. Therefore, we examined whether the DULIP assay can 
detect the effect of mutations on the well-described interaction between the synaptic 
proteins Munc18 and Syntaxin-144; 45; 46. Previous studies have demonstrated that 
point mutations in Munc18 reduce its binding affinity for the protein Syntaxin-1 (Fig. 
5a and b), suggesting that such effects on interaction strength should also be 
detectable with DULIP assays. To address this question we co-produced the bait 
protein PA-RL-Syntaxin-1 with the prey proteins FL-Munc18-wt, FL-Munc18-K46E, 
FL-Munc18-E59K or FL-Munc18-K46E/E59K in HEK293 cells and determined cNIRs 
for these PPIs. We found that the interaction between PA-RL-Syntaxin-1 and FL-
Munc18-wt can be readily detected with DULIP assays (Fig. 5c), confirming 
previously published results44; 45; 46. However, the interactions between PA-RL-
Syntaxin-1 and the mutant proteins FL-Munc18-K46E, FL-Munc18-E59K and FL-
Munc18-K46E/E59K were not identifiable. This demonstrates that the effects of both 
single and double point mutations on interaction strength can be monitored using 
standard DULIP assays.  
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Finally, we examined whether the point mutations in Munc18 influence its 
association with Syntaxin-1 in an established Y2H interaction assay3; 16 (Fig. 5d and 
e). We observed that the hybrid protein pairs Gal4-Syntaxin-1/LexA-Munc18-wt, 
Gal4-Syntaxin-1/LexA-Munc18-K46E and Gal4-Syntaxin-1/LexA-Munc18-E59K 
interact in Y2H assays. However, the interaction between Gal4-Syntaxin-1 and LexA-
Munc18-K46E/E59K was not detected. This suggests that Y2H colony growth assays 
are less sensitive for the detection of subtle changes in affinity due to single point 
mutations than DULIP assays. However, more comprehensive studies with multiple 
mutant proteins are necessary to further substantiate these results. 
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DISCUSSION 
In this study, we have established and benchmarked a dual luminescence-
based co-immunoprecipitation method – termed DULIP – that can be applied for 
systematic PPI mapping in mammalian cells. The method is an advancement of the 
previously described LUMIER method, which allows the detection of PPIs through 
quantification of luminescence activity after immunoprecipitation28; 47. Classical 
LUMIER assays have the disadvantage that bait protein immunoprecipitation cannot 
be quantified in systematic co-immunoprecipitation experiments. To overcome this 
limitation a modified LUMIER assay (LUMIER with BACON) enabling the 
quantification of precipitated FLAG-tagged bait proteins with additional ELISAs was 
recently developed28. This method is clearly an improvement of the initially described 
LUMIER assay. Through the application of LUMIER with BACON a large number of 
novel client proteins interacting with the molecular chaperone Hsp90 have been 
successfully identified28. Furthermore, the method more recently helped to establish 
a comprehensive quantitative chaperone interaction network revealing the 
architecture of protein homeostasis pathways31. For systematic mapping of PPIs on a 
proteome-wide scale with LUMIER with BACON, however, the quantification of bait 
proteins is achieved through ELISAs, which need to be performed in addition to 
luciferase assays. This is labor intensive and requires additional resources, which is 
a drawback, especially in high-throughput application of the procedure.  
To overcome these limitations we have developed DULIP, which enables the 
quantification of co-immunoprecipitated bait and prey proteins in a single sample. 
This is achieved through the co-expression of two luciferase-tagged proteins in 
mammalian cells: a Renilla luciferase (RL) fusion (bait) and a firefly luciferase (FL) 
fusion (prey) protein. Both can be quantified in the same reaction by using 
chemistries that allow the separate measurement of each luciferase. Thus, DULIP 
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assays are superior when large numbers of PPIs are to be systematically tested in 
mammalian cells with co-immunoprecipitations.  
A limitation of luminescence-based PPI methods is that data output is often 
highly variable and that assays performed on different days and in different microtiter 
plates yield quantitatively inconsistent results. This inter- and intra-assay variability is 
most probably due to the fact that the assay conditions like temperature, incubation 
time, transfection efficiency etc. cannot be controlled perfectly in repeated 
experiments and that small changes in the concentrations of transiently transfected 
plasmids have a high impact on protein expression and therefore on luminescence 
activity. To overcome these limitations it is important to standardize the different 
steps of the PPI screening procedure and to include controls which can be used for 
data normalization on each assay plate. We found that the luminescence values, 
which were obtained with the control protein PA-RL-FL (Fig. 2b and c), are suitable 
for normalization of the luminescence output of tested PPIs. Through this 
normalization step and the calculation of background corrected normalized 
interaction ratios (cNIRs) for all tested PPIs, highly reproducible, quantitative 
interaction data were obtained (Fig. 3c), which can be directly compared between 
experiments. We suggest that the control protein PA-RL-FL could be used more 
generally for normalization of measured luminescence activities in order to produce 
widely comparable, quantitative PPI data.  
In a recently reported study a pull-down PPI detection method with two 
luciferase tagged fusion proteins has been described26. In strong contrast to DULIP, 
streptavidin beads are utilized for the precipitation of biotinylated HAVI-tagged bait 
proteins. This has the disadvantage that initially a biotin ligase is required, which 
needs to be additionally co-produced in mammalian cells. However, biotin ligases are 
known to be of low specificity for their targets48. Besides the bait protein, the 
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potentially interacting prey protein might also be biotinylated. However, this 
previously reported method has not yet been systematically benchmarked with well-
defined PPI reference sets. It remains to be seen whether it is suitable for larger 
scale application and the generation of quantitative PPI data. 
Our studies with a positive PPI reference set composed of high-confidence 
PPIs from the HIPPIE database (selected PPIs with a HIPPIE score of ≥0.99) 
revealed that benchmarked DULIP assays (cNIR cutoff ≥3) can detect known human 
PPIs with a sensitivity of ~79.5% (Fig. 3e). This was a surprisingly high, unexpected 
PPI detection rate as many previously published PPI detection assays recovered 
binary interactions from positive reference sets with success rates of 20-35%8; 20. We 
therefore performed an additional assessment of the method’s sensitivity using the 
hsPRS-v1 reference set, which has already been applied for the benchmarking of 
multiple PPI detection methods8; 20; 39. Interestingly, positive PPIs were recovered 
from hsPRS-v1 with a success rate of ~35% (Fig. 3e), which is in good agreement 
with many previously published studies. Thus, our benchmarking studies with 
hsPRS-v1 and hsRRS-v1 indicate that DULIP performs similarly well as other 
previously described PPI detection methods like LUMIER8; 20. This is also supported 
by our studies with a newly generated affinity-based interaction reference set, AIRS, 
which contains a broad spectrum of lower and higher affinity interactions (Fig. 4a). 
We found that DULIP assays can detect PPIs in AIRS with a sensitivity of ~30% (Fig. 
4c and d), which is in agreement with the hsPRS-v1 results and previously published 
data. The reason for the very high recovery of PPIs from the PRS (Fig. 3e) is still 
unclear. We suggest that the PRS compared to the hsPRS-v1 is enriched for high-
affinity interactions, which probably have a higher tendency to yield a positive score 
in a variety of different experimental systems. Nevertheless, our investigations of 
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various PPI reference sets indicate that DULIP is a very robust method, which allows 
the detection of PPIs with high sensitivity and specificity.                  
The generation of AIRS, which exclusively contains PPIs with published 
dissociation constants also allowed us to assess whether the quantitative 
luminescence-based output values (cNIRs) of DULIP assays provide an indication of 
interaction strength. Using PPIs from AIRS, we found a positive correlation between 
cNIRs and published Kd values (Fig. 4e), indicating that the binding strength of 
interactions indeed influences the output of DULIP assays. Thus, the detection of 
PPIs with high cNIRs suggests that relatively stable protein complexes are formed in 
mammalian cells. However, more detailed validation studies with biochemical and 
biophysical methods are necessary to further substantiate the results obtained with 
DULIP. 
Several lines of experimental evidence indicate that mutations changing the 
amino acid composition of proteins (missense point mutations and in-frame insertions 
or deletions) can influence their binding affinity43; 45; 49. To reliably monitor such 
mutation-dependent effects quantitative PPI detection methods are required. Here, 
we examined whether DULIP assays are capable of detecting the influence of point 
mutations on interaction strength. We focused our efforts on the well-characterized 
interaction between Munc18 and Syntaxin-1, which plays a functional role in synapse 
communication44; 45; 46. Previous biochemical studies have demonstrated that the 
point mutations K46E and E59K decrease the binding affinity of this interaction45, 
suggesting that such a reduction should also be detectable with DULIP assays. 
Strikingly, our studies confirmed the effect of K46E and E59K on the interaction 
between Munc18 and Syntaxin-1 (Fig. 5c), indicating that the method is well-suited 
for monitoring the impact of point mutations on interaction strength with high potential 
for the investigation of disease-causing mutations.   
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We propose that DULIP is a highly valuable method for the identification of 
PPIs in mammalian cells. It can be applied for high-throughput PPI screening as well 
as for the validation of PPIs identified with other methods such as the Y2H system8; 
15. DULIP assays are suitable for the quantitative analysis of PPIs, enabling the 
detection of PPIs with different interaction strengths and the analysis of the impact of 
mutations, therapeutic molecules or posttranslational modifications on the 
association of proteins. 
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MATERIALS & METHODS 
Plasmid construction 
DULIP vectors pPA-RL-GW and pFL-V5-GW for the production of N-terminal fusions 
were described previously50. For the generation of vectors encoding C-terminal 
fusion proteins the sequences coding for Renilla luciferase (RL) and protein A (PA) 
were amplified from pPA-RL-GW with primers 5’-
GCTGTAAAGCTTATGGCTTCCAAGGTGTACG-3’, 5’-
GCTGTAGAATTCCTGCTCGTTCTTCAGCAC-3’ (RL), 5’-
GCTGTAGAATTCGGCTCGGGCTCGATGGTGGACAACAAATTCAAC-3’ and 5’-
GCTGTACTCGAGTCACGAGTTCGCGTCTACTTTC-3’ (PA). The resulting PCR 
fragments were cloned simultaneously in pcDNA3.1(+) (Invitrogen) via 
HindIII/EcoRI/XhoI restriction sites to obtain pRL-PA. Firefly-V5 cDNA was PCR 
amplified from pFL-V5-GW with primers 5’-
GCTGTAAAGCTTATGGAAGACGCCAAAAACATAAAG-3’ and 5’-
GCTGTACTCGAGTCACGTAGAAT CGAGACCGAGGAG-3’ and cloned in 
pcDNA3.1(+) via HindIII/XhoI restriction sites to obtain pFL-V5. Subsequently, the 
Gateway cassette (GW) was PCR-amplified from pBTM116-D93 and cloned into 
pReni-PA and pFire-V5 using NheI/HindIII restriction sites, resulting in pGW-RL-PA 
and pGW-FL-V5. The plasmid pdECFP-C1 was kindly provided by Dr. Stefan 
Wiemann (DKFZ). The plasmid pdEYFP-C1 was obtained from a commercial 
supplier (ImaGenes). As the gateway destination vectors that contain no insert but 
the gateway cassette show a weak expression in HEK293 cells, we removed the 
gateway cassette from the vectors pdEYFP-C1 and pdECFP-C1. An oligonucleotide 
adaptor 5’-ATAAGTGGCCGGCCACT-3’ was self-annealed and cloned into pdEYFP-
C1 and pdECFP-C1 via BspEI/XbaI restriction sites to obtain pdEYFP and pdECFP. 
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For generation of pPA-RL-mCherry, pFL-mCherry and pPA-RL-FL, the coding 
sequence of mCherry was amplified from pmCherryGW27 (Invitrogen) and the firefly 
luciferase coding sequence from pFL-V5-GW. For cloning of mCherry the primers 5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGTGAGCAAGGGCGAGGAGG
ATAAC-3’ and 5’-
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTTGTACAGCTCGTCCATGCCG-3’ 
and for the firefly luciferase 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCG 
CCACCATGGAAGACGCCAAAAAC-3’ and 5’-
GGGGACCACTTTGTACAAGAAAGCTGGGTCCACG GCGATCTTTCCGCCCTTC-
3’ were used. To generate a Syntaxin-1 fragment that lacks the Syntaxin-1 
transmembrane domain the primers 5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAAGGACCGAACCCAGGA-3’ 
and 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCGCCTTGCTCTGGTACTTG-
3’ were used for PCR amplification (1-261 aa, Syntaxin-1∆TM) from the entry clone 
RZPDo834H065D. The resulting PCR fragments were shuttled into pDONR221 
(Invitrogen) with the BP clonase (Invitrogen) to generate entry plasmids that can be 
used for shuttling into destination plasmids. To introduce the single and double point 
mutants K46E and E59K into Munc18, the 5’-phosphorylated primers 5’-
ATGACAGACATCATGACCGAGG-3’ and 5’-CTCGCAGCAGGAGGACAGCATC-3’ 
(K46E) as well as 5’-GATATCAACAAGCGCCGAGAGC-3’ and 5’-
CTTCACAATTGTGATGCCCTCG-3’ (E59K) were used for PCR amplification. The 
Munc18 wild-type cDNA from the pENTRZ-Munc18 construct that was kindly 
provided by Prof. Dr. Matthijs Verhage (Vrije Universiteit). The resulting entry vectors 
harboring the genes encoding the proteins Munc18-wt, Syntaxin-1, BAD and BCL2L1 
were utilized to generate the plasmids pPA-RL-GW, pFL-V5-GW, pBTM116-D9, 
pACT4-DM, pdEYFP-C1 and pdECFP-C1 using the LR clonase. Similarly, the 
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cDNAs encoding the proteins for the MDC positive and negative reference sets (Tab. 
S2 and S3), the CCSB reference sets (Tab. S4) as well as AIRS (Tab. S5) were 
shuttled into the vectors pPA-RL-GW, pGW-RL-PA, pFL-V5-GW or pGW-FL-V5 
using the LR clonase.  
Cell culture and transfection 
The human embryonic kidney cell line 293 (HEK293) was grown in DMEM 
supplemented with 10% heat inactivated fetal bovine serum at 37°C, 5% CO2. Cells 
subcultured every 3-4 days were transfected with linear polyethyleneimine (25 kDa, 
Polysciences) using the reverse transfection method according to the manufacturer’s 
instructions. For FRET and luminescence measurements the cells were examined 24 
or 48 h after transfection.  
DULIP assay 
HEK293 cells were reversely transfected in 96 well microtiter plates at a density of 
3.75x104 cells per well. 48 h after transfection cells were lysed in 100 µl HEPES lysis 
buffer (50 mM HEPES, 150 mM NaCl, 10% glycerol, 1% NP-40, 0.5% Deoxycholate, 
20 mM NaF, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 U Benzonase, protease 
inhibitor cocktail (Roche, EDTA free), 1 mM PMSF) for 30 min at 4°C. Production of 
PA-RL- and FL-tagged fusion proteins was monitored by measuring the respective 
luciferase activities in crude cell lysates in 384-well microtiter plates. 10 µl of the cell 
lysate were added to 20 µl PBS and 10 min after the addition of 10 µl Dual-Glo® 
luciferase reagent (Promega) the firefly activity (FLIN) was measured using an 
Infinite® M1000 (Tecan) plate reader. To stop the firefly luciferase activity and to 
measure the Renilla luciferase activity (RLIN), 10 µl of the Dual-Glo® Stop & Glow® 
reagent (Promega) were added and after 15 min of incubation the activity was 
measured. In parallel, 50 µl of the cell lysate were incubated for 3 hours at 4°C in IgG 
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pre-coated 384-well microtiter plates. Plates were coated with sheep gamma globulin 
(Dianoca), blocked with 1% BSA in carbonate buffer (70 mM NaHCO3, 30 mM 
Na2CO3, pH 9.6) before they were incubated with rabbit anti-sheep IgGs (Dianova) 
overnight. After cell lysate incubation, all wells were washed three times with HEPES 
lysis buffer before 30 µl of PBS were added to each well. Measurement of firefly 
(FLOUT) and Renilla (RLOUT) luminescence activity was performed using an Infinite® 
M1000 (Tecan) plate reader. 
DULIP data analysis 
To identify weakly expressing preys and weakly immunoprecipitated baits, the 
measured firefly or Renilla luciferase activities were log2-transformed and the 
distribution of measured luminescence values for the controls 1 or 2 (Fig. 2d) was 
binned. As the expression and immunoprecipitation profiles followed Gaussian 
distributions, we used a Gaussian curve fit to determine the mean (µ) and standard 
deviation (σ) of the firefly and Renilla luciferase activities. Preys were classified as 
not expressed when the mean luminescence of the three technical replicates was 
smaller µ-3σ. Similarly, bait immunoprecipitation efficiency was analyzed and 
proteins were classified as not immunoprecipitated when the mean luminescence of 
the three technical replicates was smaller µ-3σ. To exclude unspecific background 
binding of prey proteins to antibodies or assay plates, FLOUT values of PPIs of 
interest were divided by FLOUT values of control PPIs (control 1 and 2, see Fig. 2a 
and Fig. S1). This revealed luminescence-based interaction control ratios (ICRs) for 
each PPI of interest, which were used for quality assessment of PPI detection 
experiments. In systematic interaction detection studies only PPIs of interest with 
ICRs ≥ 3 were further analyzed and the luciferase immunoprecipitation ratios (LIRs) 
of control 3 (see Fig. 2a) were used to calculate the normalized immunoprecipitation 
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ratios (NIRs) of PPIs of interest. The NIR is a measure for the success of prey protein 
co-immunoprecipitation in relation to the success of bait protein immunoprecipitation. 
Finally, to correct for unspecific background binding, we calculated the background 
corrected NIRs (cNIRs). The NIR value obtained for control 1 or 2 was subtracted 
from the calculated NIR of the interaction of interest (see also Fig. 2a and Fig. S1).  
Positive and negative reference set creation 
The MDC positive reference set (PRS) was generated from literature known PPIs 
using the HIPPIE (Human Integrated Protein-Protein Interaction rEference) 
database37. HIPPIE provides a scoring algorithm that allows a distinction between 
higher and lower confidence literature PPIs. For the creation of a positive reference 
set 25 high confidence PPIs with a HIPPIE score of ≥0.99 were chosen, of which 23 
were finally tested in DULIP assays. To compile a negative reference set (NRS) the 
Negatome database (v1.0) was searched for PPIs that were not detected with at 
least 3 independent methods38. The cDNAs encoding 30 protein pairs were randomly 
selected and shuttled successfully into DULIP destination plasmids. The CCSB 
reference sets hsPRS-v1 and hsRRS-v1 were previously described39.  
Creating an affinity-based interaction reference set (AIRS) 
The affinity-based reference set (AIRS) was generated from literature PPIs with 
known dissociation constants using PDBbind40 and the Protein-Protein Interaction 
Affinity Database 2.041. From PDBbind 47 PPIs and from PPIAD 12 PPIs were 
selected to cover a broad range of protein binding affinities. The cDNAs encoding 57 
selected PPIs were shuttled into expression plasmids and tested in DULIP assays. 
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FRET measurements 
HEK293 cells were reversely transfected in 96-well microtiter plates at a density of 
6×104 cells per well. 24 h after transfection cells were fixed with 4% 
paraformaldehyde in PBS and washed twice with PBS. Fluorescence signals were 
detected with the Infinite® M1000 (Tecan) plate reader: donor channel [excitation 
(Ex)/emission (Em): 435 nm/475 nm], acceptor channel (Ex/Em: 500 nm/530 nm) 
and FRET channel (Ex/Em: 435nm/530 nm). For processing of raw data the 
fluorescence intensities obtained with empty vector transfected cells were used. 
Signals in the FRET channel (DA) were corrected for spectral bleed through of the 
donor (cD) and acceptor cross-excitation (cA) with samples expressing the donor or 
acceptor construct only. Finally, corrected signals in the FRET channel were 
normalized to the acceptor signals35. In brief, FRET efficiency (EAapp) in % was 
calculated as follows: EAapp = (DA-cD×DD-cA×AA)/AA with DD = donor channel signal 
and AA = acceptor channel signal.  
Yeast-two hybrid 
The Y2H interaction mating assays were performed as previously described3; 16. 
Briefly, bait and prey constructs were transformed into yeast strains L40ccua (MATa) 
and L40ccα (MATα), respectively. For interaction mating, 100 µl cultures of MATa 
yeast strains were transferred into 96-well microtiter plates and mixed with 100 µl 
cultures of MATα yeast strains. The yeast mixtures were then spotted onto YPD agar 
plates using a spotting robot (KBiosystem). After mating for 48 h at 30°C, the yeast 
colonies were automatically picked and transferred into 96-well microtiter plates 
containing selective liquid medium (SDII-Leu-Trp). Finally, for selection of PPIs 
diploid yeasts were spotted in parallel onto SDIV (-Leu-Trp-Ura-His) and SDII (-Leu-
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Trp) selective agar plates. After 5-6 days of incubation at 30°C agar plates were 
imaged and yeast growth assessed by visual inspection. 
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FIGURE LEGENDS 
Fig. 1: DULIP vectors and proteins utilized for PPI testing. 
(a) Scheme of Gateway compatible plasmids for expression of bait and prey hybrid 
proteins. AttR sites flank the gateway cassette (GW) and allow the introduction of 
open-reading frames via LR recombination reaction. Bait vectors enable the 
expression of N- or C-terminally tagged RL fusions harboring also a protein A (PA) 
tag. The PA tag facilitates the efficient immunoprecipitation of bait proteins. Prey 
vectors encode N- or C-terminally tagged FL fusion proteins. The prey proteins 
additionally harbor a V5 epitope tag for their detection on immunoblots. RL: Renilla 
luciferase; FL: firefly luciferase; PA: Protein A; V5: V5-tag; Amp: ampicillin resistance; 
Neo: neomycin resistance; Cam: chloramphenicol resistance; ccdB: ccdB gene; 
AttR1/AttR2: Gateway® recombination sites; GW: Gateway® cassette. (b) Schematic 
depiction of hybrid fusion proteins utilized to study the published interaction between 
BAD and BCL2L1 with DULIP assays.  
 
Fig. 2: Investigating the interaction between BAD and BCL2L1 with DULIP 
assays. 
(a) Schematic representation of the DULIP approach. To assess the interaction 
between the proteins BAD (bait) and BCL2L1 (prey) the fusion proteins PA-RL-
BAD/FL-BCL2L1 (PPI), PA-RL-BAD/FL-mCherry (Control 1) and PA-RL-mCherry/ 
FL-BCL2L1 (Control 2) were co-produced in HEK293 cells. In addition, cells were 
analyzed expressing the fusion protein PA-RL-FL (Control 3). (b) Analysis of protein 
expression through quantification of RL and FL luminescence activities in cell lysates. 
Cell lysates were investigated 48 h post transfection (c) Analysis of co-
immunoprecipitates through quantification of RL and FL luciferase activities. The PA-
 33 
tagged bait proteins were immunoprecipitated in IgG-coated microtiter plates. (d) 
Calculation of normalized interaction ratios (NIRs) for tested PPIs. The NIR for the 
interaction PA-RL-BAD/FL-BCL2L1 was significantly higher than the NIRs for the 
control PPIs PA-RL-BAD/FL-mCherry, PA-RL-mCherry/FL-BCL2L1. Finally, for the 
PPI of interest PA-RL-BAD/FL-BCL2L1 a background corrected normalized 
interaction ratio (cNIR) was calculated. All values are means of two independent 
experiments performed in triplicates each ± SEM. Two-tailed unpaired t-test; 
***p<0.001. 
 
 
Fig. 3: Systematic analysis of positive and negative interaction reference sets 
using DULIP assays. 
(a) Selection strategy for interaction pairs compiled in the positive reference set 
(PRS). From 181 PPIs with a confidence score ≥ 0.99 (HIPPIE database) 25 protein 
pairs were randomly selected, of which 23 were examined in DULIP assays. (b) 
Selection scheme for PPIs compiled in the negative reference set (NRS). We 
selected 30 PPIs from the Negatome database (v1.0) for systematic interaction 
testing in DULIP assays. (c) Investigation of the reproducibility of DULIP PPI 
mapping experiments. cNIR values were calculated for all interactions of the PRS 
and the NRS. The scatter plot shows the mean cNIRs of three technical replicates 
from two biological replicates (expiments 1 and 2). Error bars are SEM of three 
technical replicates. (d) Estimation of assay sensitivity through receiver operating 
characteristic (ROC) analysis. A cNIR of ≥3 was optimal to separate positive and 
negative PPIs with DULIP assays. (e) With a benchmarked DULIP assay high-
confidence human PPIs were detected with a sensitivity of 79.5% and a specificity of 
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96.7% in the MDC-generated reference sets. In the previously published CCSB 
reference sets hsPRS-v1 and hsRRS-v1 PPIs were recovered with a success rate of 
34.8 and 3.7%, respectively. (f) and (g)  Interactions with the higher luminescence-
based interaction ratios are shown from the MDC PPI sets a and b. Values are 
displayed as a bar diagram (means ± SEM of two biological replicates). PPIs 
surpassing the cNIR threshold (dotted line) are considered positive and are colored 
blue. Negative PPIs are indicated by red color. 
 
Fig. 4: Systematic analysis of interactions with known binding affinities using 
the DULIP assay. 
(a) Selection strategy for interaction pairs compiled in the affinity-based interaction 
reference set (AIRS). We selected 57 PPIs from PDBbind and the Protein-Protein-
Interaction Affinity Database 2.0 and systematically tested them in DULIP assays. (b) 
The selected 57 PPIs in the AIRS span a broad range of binding affinities. (c) 
Detection rate of PPIs with DULIP assays in relation to their published binding 
affinities. (d) Number of tested PPIs for the respective binding affinity range and 
numbers of interactions detected with DULIP assays. (e) Published dissociation 
constants of DULIP positive interactions plotted against luminescence-based cNIR 
values. Linear regression plotted as dashed line. Pearson correlation: *p<0.05.  
 
Fig. 5: Point mutations influence the association between Munc18 and 
Syntaxin-1 in interaction detection assays. 
(a) High resolution structure depicting the binding interface of the Syntaxin-1 (amino 
acids 110-121 and 222-240) and Munc18 (amino acids 30-61) protein complex 
(Burkhardt 2008 EMBO; PDB: 3C98). Point mutations in Munc18 that influence the 
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interaction strength are highlighted. (b) Previously published studies indicate that 
point mutations influence the binding affinity of the interacting proteins Munc18 and 
Syntaxin-144; 45; 46; nd: not determined; -: no interaction detected. (c) Analysis of the 
effects of point mutations on the interaction between Munc18 and Syntaxin-1 with 
DULIP. For all tested protein pairs cNIRs were determined. Values are the means of 
two independent experiments performed in triplicates each ± SEM. The dotted line 
indicates the threshold (cNIR ≥3) above which positive PPIs are scored with DULIP 
assays. (d) Analysis of the effects of point mutations on the interaction between 
Munc18 and Syntaxin-1 with Y2H interaction assays. Representative interaction 
mating experiments on selective agar plates are shown. (e) Quantification of data 
from Y2H interaction mating experiments. The data from eight mating experiments 
with three technical replicates each were analyzed. Bars represent mean values ± 
SEM. Statistical significance was assessed by two-sided Fisher’s exact test; 
***p<0.001. 
 
Fig. S1: Step-by-step instructions for DULIP data analysis.  
Step 1: Measure Expression (IN). Transfected cells are lysed and the expression of 
bait and prey proteins was measured through quantification of luminescence 
activities. Preys with significantly weaker firefly activity (FLIN) than the FLIN mean 
signals of all control 1 preys are excluded from further data analysis.  
Step 2: Measure Immunoprecipitation (OUT). Cell lysates are subjected to 
immunoprecipitation and the RLOUT and FLOUT luciferase activities in the 
immunoprecipitates are finally measured. Baits that are insufficiently 
immunoprecipitated are excluded from further data analysis if their measured RLOUT 
activities are significantly lower than the mean RLOUT signals of all Control 2 baits. 
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Step 3: Interaction Control Ratios (ICRs). FLOUT values of PPIs of interest were 
divided by FLOUT values of control PPIs (control 1 and 2, see Fig. 2a and Fig. S1). 
This revealed luminescence-based interaction control ratios (ICRs) for each PPI of 
interest, which were used for quality assessment of PPIs. Only PPIs of interest with 
ICRs ≥ 3 were further analyzed.  
Step 4: Normalized Immunoprecipitation Ratios (NIRs). The normalized 
immunoprecipitation ratio (NIR) is determined as the relative amount of FL-X that is 
bound to PA-RL-Y in relation to the PA-RL-FL tandem construct (Control 3).  
Step 5: Background corrected NIRs (cNIRs). The relative background binding of 
each tested bait or prey protein to the luciferase fused to an unrelated protein 
(mCherry) is determined. The protein (bait or prey) that gives the higher background 
is subtracted from the calculated NIR of each protein of interest. More detailed 
information is also provided in the materials and methods section. 
 
Fig. S2: Investigating the interaction between BAD and BCL2L1 using Y2H and 
FRET assays. 
(a) Representative interaction mating experiment. Diploid yeast strains co-expressing 
the proteins LexA-BAD/Gal4-BCL2L1, LexA-mCherry/ Gal4-BCL2L1 or Gal4-
LexA/Gal4-mCherry were analyzed. (b) Quantification of yeast colony growth. 12 
independent mating experiments with three technical replicates each were analyzed. 
Bars represent mean values ± SEM. Two-sided Fisher’s exact test; ***p<0.001. (c) 
Analysis of the interaction between BAD and BCL2L1 using FRET assays. HEK293 
cells were assessed 24 h post transfection using a fluorescence plate reader. FRET 
values for tested protein combinations were calculated using the sensitized emission 
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method. FRET efficiencies are the mean values of three independent experiments 
performed in triplicates each ± SEM (ns: non-significant, ***p<0.001).  
  
Fig. S3: Overview of selected PPIs for DULIP benchmarking studies. 
(a) Schematic representation of tested PPIs from the PRS and the NRS generated at 
the MDC. PPIs were assessed in both configurations (set a and b) in two 
independent experiments (Exp 1 and 2). Green color indicates PPIs that were 
successfully screened with DULIP assays. PPIs for which cloning failed (blue 
triangles), prey proteins were not expressed (yellow triangles) or bait proteins were 
insufficiently immunoprecipitated (red triangles) were excluded from further analysis. 
(b) Estimation of prey protein expression. FL signals (FLIN) obtained for preys are 
presented as a frequency distribution. Data from two biological replicates (Exp 1 and 
2) were log2-transformed prior to analysis. Based on the log2-transformed FL signals 
of PPIs examined in control 1 experiments (Fig. 2d), a Gaussian fit was applied to 
identify non-expressed prey proteins (broken lines). (c) Estimation of the success of 
bait immunoprecipitation. Bait RL signals (RLOUT) from experiments 1 and 2 were 
log2-transformed and presented as a frequency distribution. Based on the log2-
transformed RL signals of PPIs examined in control 2 experiments, a Gaussian fit 
was applied to identify bait proteins that are insufficiently immunoprecipitated (broken 
lines).  
 
Fig. S4: Comparison of biological replicates of DULIP tested PPIs. 
(a) and (b) Representation of PPIs from the PRS (sets a and b). Data (cNIRs) are 
displayed as means ± SEM from three technical replicates each for experiments 1 
and 2. Positive PPIs are shown in dark (Exp 1) or light blue (Exp 2) colors. Negative 
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PPIs are presented in red (Exp 1 and 2) colors. (c) and (d) Representation of PPIs 
from the NRS; cNIRs calculated for PPIs from the sets a and b are shown using the 
same color code as in a and b.  
 
Fig. S5: Systematic analysis of PPIs in hsPRS-v1 and hsRRS-v1 reference sets 
using DULIP assays. 
(a) and (b) From 92 PPIs in the published hsPRS-v1 and hsRRS-v1 reference sets 
82 PPIs were selected in each case and examined in DULIP assays. (c) and (d) Data 
are displayed as cNIRs for the PPI sets a and b. Values are displayed as a bar 
diagram (means ± SEM of two biological replicates). PPIs surpassing the cNIR 
threshold (dotted line) are considered positive and are colored blue. Negative PPIs 
are indicated by red color. 
 
Fig. S6: Selected PPIs from the reference sets hsPRS-v1 and hsRRS-v1 for 
DULIP interaction studies. 
(a) and (b) Schematic representation of tested PPIs from the hsPRS-v1 and the 
hsRRS-v1 reference sets; PPIs were examined in two configurations (sets a and b) 
and two independent experiments (Exp 1 and 2). Green color indicates PPIs that 
were successfully screened with DULIP assays. PPIs that were not cloned (blue 
triangles), prey proteins not expressed (yellow triangles) or bait proteins insufficiently 
immunoprecipitated (red triangles) were excluded from further analysis. 
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1Han et al., 201141; 2Meijer et al., 201242
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Figure S5
(a)
H. sapiens random reference set
hsRRS-v1: 92 PPIs
82 PPIs tested
(b)
hsPRS-v1: 92 PPIs 
H. sapiens positive reference set
82 PPIs tested
(c)
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